Carbon-Defect-Driven Boron Carbide for Dual-Modal NIR-II/Photoacoustic Imaging and Photothermal Therapy

Recently, tremendous attention has been evoked in the discovery of defect-engineered nanomaterials for near-infrared second window (NIR-II)-driven cancer therapy. Herein, we have constructed a novel type of carbon defects enriched in boron carbide nanomaterial (denoted as B4C@C) through reacting B4C...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ACS biomaterials science & engineering 2021-07, Vol.7 (7), p.3370-3378
Hauptverfasser: Guo, Shuaitian, Li, Ran, Tian, Fangzhen, Yang, Xueting, Wang, Li, Guan, Shanyue, Zhou, Shuyun, Lu, Jun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Recently, tremendous attention has been evoked in the discovery of defect-engineered nanomaterials for near-infrared second window (NIR-II)-driven cancer therapy. Herein, we have constructed a novel type of carbon defects enriched in boron carbide nanomaterial (denoted as B4C@C) through reacting B4C and glucose by a hydrothermal method. The carbon defect concentration in B4C@C has been significantly increased after coating with glucose; thus, B4C@C exhibited a distinct photothermal response under the NIR-II window and the efficiency of photothermal conversion is determined to reach 45.4%, which is higher than the carbon-based nanomaterials in the NIR-II region. Both Raman spectra and X-ray photoelectron spectroscopy (XPS) spectra reveal that B4C@C has rich sp2-hybridized carbon defects and effectively increases the NIR-II window light absorption capacity, thus enhancing the nonradiative recombination rate and improving the NIR-II photothermal effect. Furthermore, the B4C@C nanosheets allows for tumor phototherapy and simultaneous photoacoustic imaging. This work indicates the huge potential of B4C@C as a novel photothermal agent, which might arise much attention in exploring boron-based nanomaterials for the advantage of cancer therapy.
ISSN:2373-9878
2373-9878
DOI:10.1021/acsbiomaterials.1c00578